n-acetylsphingosine has been researched along with Disease Models, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Bae, JS; Choi, MK; Han, SH; Jin, HK; Kim, HJ; Kim, SH; Lee, JY; Park, CM; Park, MH; Schuchman, EH; Song, IS; Yu, E | 1 |
Adeli, K; Baker, C; Dekker, MJ; Naples, M; Qiu, W; Sacco, J; Samsoondar, J; Zhang, R | 1 |
Khodorova, A; Nicol, GD; Strichartz, G | 1 |
Abi-Habib, RJ; Asaad, W; Dbaibo, GS; El Sabban, ME; Farhat, F; Kobeissi, M; Kurdi, RM; Mikati, MA | 1 |
Chen, Y; Ginis, I; Hallenbeck, JM | 1 |
6 other study(ies) available for n-acetylsphingosine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease.
Topics: Acetyl Coenzyme A; Acetylation; Alzheimer Disease; Animals; Anti-Inflammatory Agents; Brain; Cell Line; Cyclooxygenase 2; Disease Models, Animal; Humans; Male; Memory; Mice; Mice, Transgenic; Microglia; Mutagenesis; Neurons; Phagocytosis; Phosphotransferases (Alcohol Group Acceptor); Presenilin-1; Primary Cell Culture; Recombinant Proteins; Serine; Sphingosine | 2020 |
Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Topics: Animal Feed; Animals; Apolipoprotein B-100; Cricetinae; Dietary Fats; Disease Models, Animal; Dyslipidemias; Fatty Acids, Monounsaturated; Fructose; Glucose Intolerance; Hepatitis; Immunosuppressive Agents; Insulin Resistance; Lipoproteins, VLDL; Liver; Male; Mesocricetus; Signal Transduction; Sphingolipids; Sphingosine | 2013 |
The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor.
Topics: Analgesics; Aniline Compounds; Animals; Antibodies; Benzylidene Compounds; Carbazoles; Disease Models, Animal; Enzyme Inhibitors; Hot Temperature; Hyperalgesia; Indole Alkaloids; Male; Nerve Growth Factor; Nerve Tissue Proteins; Protein Kinase C; Rats, Sprague-Dawley; Receptor, trkA; Receptors, Growth Factor; Receptors, Nerve Growth Factor; Sphingosine; Touch; TRPV Cation Channels | 2017 |
Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms.
Topics: Age Factors; Animals; Apoptosis; Ceramides; Disease Models, Animal; Dizocilpine Maleate; DNA Fragmentation; Dose-Response Relationship, Drug; Hippocampus; Injections, Intraperitoneal; Kainic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sphingosine; Status Epilepticus | 2003 |
The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells.
Topics: Animals; Apoptosis; Brain; Disease Models, Animal; Gene Expression Regulation; Genes, bcl-2; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Infusions, Parenteral; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingosine; Stereotaxic Techniques; Tumor Necrosis Factor-alpha | 2001 |